Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
This Strategy Could Boost GILD’s HIV Franchise Revenue in 2017
Market Realist
Thu, 02/23/17 - 09:47 pm
Gilead Sciences
HIV
Top 10 U.S. patent losses of 2017
Fierce Pharma
Thu, 02/23/17 - 09:29 am
patents
Copaxone
Cialis
Viagra
Velcade
Sustiva
Sandostatin LAR
Norditropin
Viread
Pristiq
Strattera
Pfizer
Teva
Takeda
Eli Lilly
Novartis
Bristol-Myers Squibb
Novo Nordisk
Gilead Sciences
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
Fierce Pharma
Thu, 02/23/17 - 09:21 am
Gilead Sciences
hepatitis C
baby boomers
DTC advertising
Harvoni
Sovaldi
3 Things Gilead Sciences' CEO Just Said That You'll Want to Know
Motley Fool
Wed, 02/22/17 - 05:10 pm
Gilead Sciences
Pharma CEOs
John Milligan
hepatitis C
HIV
M&A
Sarepta Sells Priority Review Voucher for $125M
Investopedia
Tue, 02/21/17 - 12:23 pm
Sarepta Therapeutics
Gilead Sciences
priority review
FDA
Gilead offloads a PhII-ready addiction therapy to an upstart which knows this drug well
Endpoints
Sat, 02/18/17 - 02:21 pm
Gilead Sciences
addiction
GS-6637
CV Therapeutics
Gilead challenges GSK with strong HIV drug data
Yahoo/Reuters
Tue, 02/14/17 - 09:28 am
Gilead Sciences
GSK
HIV
bictegravir
Dolutegravir
Is Gilead Sciences Getting Ready for a Massive Acquisition?
Motley Fool
Mon, 02/13/17 - 10:12 am
Gilead Sciences
M&A
Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Medical Marketing and Media
Thu, 02/9/17 - 11:16 am
Gilead Sciences
social media
Truvada
HIV
GlaxoSmithKline and Gilead to face off at HIV meeting next week
Yahoo/Reuters
Thu, 02/9/17 - 09:44 am
GSK
Gilead Sciences
HIV
bictegravir
Dolutegravir
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Wed, 02/8/17 - 09:27 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Wed, 02/8/17 - 09:21 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead 2017 hepatitis C sales forecast disappoints, shares drop
Yahoo/Reuters
Tue, 02/7/17 - 06:31 pm
Gilead Sciences
earnings
3 Crucial Questions Gilead Sciences Should Answer Tuesday
Motley Fool
Sun, 02/5/17 - 12:47 pm
Gilead Sciences
earnings
3 Critical Things to Watch in Gilead Sciences' Q4 Results
Motley Fool
Wed, 02/1/17 - 09:47 am
Gilead Sciences
earnings
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:39 pm
Merck
Sanofi
Eli Lilly
Pfizer
Roche
AstraZeneca
Gilead Sciences
Allergan
GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Bristol-Myers Squibb
Merck
Roche
Gilead Sciences
Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company
Motley Fool
Wed, 01/25/17 - 09:53 am
Gilead Sciences
Incyte
M&A
Galapagos
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Mon, 01/23/17 - 10:26 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Vemlidy Hep B Drug Approved In EU
Investopedia
Sun, 01/15/17 - 11:16 am
Gilead Sciences
hepatitis B
Vemlidy
Europe
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »